{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T02:35:08Z","timestamp":1790217308163,"version":"4.1.0"},"reference-count":45,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2017,1,1]],"date-time":"2017-01-01T00:00:00Z","timestamp":1483228800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Pharmaceutics"],"published-print":{"date-parts":[[2017,1]]},"DOI":"10.1016\/j.ijpharm.2016.12.005","type":"journal-article","created":{"date-parts":[[2016,12,5]],"date-time":"2016-12-05T06:01:08Z","timestamp":1480917668000},"page":"96-103","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":37,"title":["In vitro inhibition of Clostridium difficile by commercial probiotics: A microcalorimetric study"],"prefix":"10.1016","volume":"517","author":[{"given":"Mansa","family":"Fredua-Agyeman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Stapleton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdul W.","family":"Basit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony E.","family":"Beezer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon","family":"Gaisford","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijpharm.2016.12.005_bib0005","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1016\/S0140-6736(13)61218-0","article-title":"Lactobacilli and bifidobacteria in the prevention of antibiotic-associated diarrhoea and Clostridium difficile diarrhoea in older inpatients (PLACIDE): a randomised, double-blind, placebo-controlled, multicentre trial","volume":"382","author":"Allen","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/j.ijpharm.2016.12.005_bib0010","first-page":"6","article-title":"Antimicrobial activity associated with Bifidobacterium bifidum-I","volume":"2","author":"Anand","year":"1984","journal-title":"Cult. Dairy Prod. J."},{"key":"10.1016\/j.ijpharm.2016.12.005_bib0015","first-page":"21","article-title":"Antimicrobial activity associated with Bifidobacterium bifidum-II","volume":"2","author":"Anand","year":"1985","journal-title":"Cult. Dairy Prod. J."},{"key":"10.1016\/j.ijpharm.2016.12.005_bib0020","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1093\/jac\/dkn313","article-title":"Emergence of reduced susceptibility to metronidazole in Clostridium difficile","volume":"62","author":"Baines","year":"2008","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.ijpharm.2016.12.005_bib0025","doi-asserted-by":"crossref","first-page":"1808","DOI":"10.1128\/AEM.45.6.1808-1815.1983","article-title":"Detection and activity of Lactacin B, a bacteriocin produced by Lactobacillus acidophilus","volume":"45","author":"Barefoot","year":"1983","journal-title":"Appl. Environ. Microbiol."},{"key":"10.1016\/j.ijpharm.2016.12.005_bib0030","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1056\/NEJMcp011603","article-title":"Clinical practice: antibiotic-associated diarrhea","volume":"346","author":"Bartlett","year":"2002","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ijpharm.2016.12.005_bib0035","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1111\/j.1365-2672.1976.tb00620.x","article-title":"Application of flow microcalorimetry to analytical problems: the preparation, storage and assay of frozen inocula of Saccharomyces cerevisiae","volume":"41","author":"Beezer","year":"1976","journal-title":"J. Appl. Bacteriol."},{"key":"10.1016\/j.ijpharm.2016.12.005_bib0040","series-title":"Biological Microcalorimetry","author":"Beezer","year":"1980"},{"key":"10.1016\/j.ijpharm.2016.12.005_bib0045","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1574-6968.2009.01819.x","article-title":"Use of isothermal microcalorimetry to monitor microbial activities","volume":"303","author":"Braissant","year":"2010","journal-title":"FEMS Microbiol. Lett."},{"key":"10.1016\/j.ijpharm.2016.12.005_bib0050","doi-asserted-by":"crossref","DOI":"10.2807\/ese.13.41.19000-en","article-title":"Distribution and antimicrobial susceptibility patterns of Clostridium difficile PCR ribotypes in English hospitals, 2007\u201308","volume":"13","author":"Brazier","year":"2008","journal-title":"Euro Surveill."},{"key":"10.1016\/j.ijpharm.2016.12.005_bib0055","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1016\/j.resmic.2010.09.007","article-title":"Clostridium difficile spore germination: an update","volume":"161","author":"Burns","year":"2010","journal-title":"Res. Microbiol."},{"key":"10.1016\/j.ijpharm.2016.12.005_bib0060","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.ijfoodmicro.2008.03.012","article-title":"Antimicrobial proteinaceous compounds obtained from bifidobacteria: from production to their application","volume":"125","author":"Cheikhyoussef","year":"2008","journal-title":"Int. J. Food Microbiol."},{"key":"10.1016\/j.ijpharm.2016.12.005_bib0065","first-page":"4","article-title":"Update on Clostridium difficile associated disease","volume":"23","author":"Cloud","year":"2007","journal-title":"Curr. Opin. Gastroenterol."},{"key":"10.1016\/j.ijpharm.2016.12.005_bib0070","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1016\/0002-9343(81)90553-2","article-title":"Epidemiology of antibiotic-associated colitis; isolation of Clostridium difficile from the hospital environment","volume":"70","author":"Fekety","year":"1981","journal-title":"Am. J. Med."},{"key":"10.1016\/j.ijpharm.2016.12.005_bib0075","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.ijpharm.2008.09.005","article-title":"An in vitro method for the quantitative determination of the antimicrobial efficacy of silver-containing wound dressings","volume":"366","author":"Gaisford","year":"2009","journal-title":"Int. J. Pharm."},{"issue":"Suppl. (1)","key":"10.1016\/j.ijpharm.2016.12.005_bib0080","doi-asserted-by":"crossref","first-page":"S43","DOI":"10.1086\/521861","article-title":"Measures to control and prevent Clostridium difficile infection","volume":"46","author":"Gerding","year":"2008","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.ijpharm.2016.12.005_bib0085","doi-asserted-by":"crossref","first-page":"e8740","DOI":"10.1371\/journal.pone.0008740","article-title":"Metabolism of bile salts in mice influences spore germination in Clostridium difficile","volume":"5","author":"Giel","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.ijpharm.2016.12.005_bib0090","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD006095.pub3","article-title":"Probiotics for the prevention of Clostridium difficile-associated diarrhea in adults and children","author":"Goldenberg","year":"2013","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.ijpharm.2016.12.005_bib0095","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1177\/1756283X11399115","article-title":"Probiotics in the prevention of antibiotic-associated diarrhoea and Clostridium difficile infection","volume":"4","author":"Hickson","year":"2011","journal-title":"Ther. Adv. Gastroenterol."},{"key":"10.1016\/j.ijpharm.2016.12.005_bib0100","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/j.ijantimicag.2009.09.012","article-title":"Antimicrobial resistance in Clostridium difficile","volume":"34","author":"Huang","year":"2009","journal-title":"Int. J. Antimicrob. Agents"},{"issue":"Suppl. (6)","key":"10.1016\/j.ijpharm.2016.12.005_bib0105","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1111\/j.1469-0691.2006.01580.x","article-title":"Emergence of clostridium difficile-associated disease in North America and Europe","volume":"12","author":"Kuijper","year":"2006","journal-title":"Clin. Microbiol. Infect."},{"key":"10.1016\/j.ijpharm.2016.12.005_bib0110","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/S0924-8579(02)00389-8","article-title":"Identification and screening for antimicrobial activity against Clostridium difficile of Bifidobacterium and Lactobacillus species isolated from healthy infant faeces","volume":"21","author":"Lee","year":"2003","journal-title":"Int. J. Antimicrob. Agents"},{"key":"10.1016\/j.ijpharm.2016.12.005_bib0115","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0040-6031(99)00491-8","article-title":"Cryopreservation of Streptococcus mutans for microcalorimetry based applications","volume":"349","author":"Morgan","year":"2000","journal-title":"Thermochim. Acta"},{"key":"10.1016\/j.ijpharm.2016.12.005_bib0120","doi-asserted-by":"crossref","first-page":"S154","DOI":"10.1097\/MCG.0b013e31822ec787","article-title":"Probiotics in Clostridium difficile infection","volume":"45","author":"Na","year":"2011","journal-title":"J. Clin. Gastroenterol."},{"key":"10.1016\/j.ijpharm.2016.12.005_bib0125","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1099\/jmm.0.45595-0","article-title":"Inhibition of Clostridium difficile strains by intestinal Lactobacillus species","volume":"53","author":"Naaber","year":"2004","journal-title":"J. Med. Microbiol."},{"key":"10.1016\/j.ijpharm.2016.12.005_bib0130","doi-asserted-by":"crossref","first-page":"2241","DOI":"10.1099\/mic.0.2008\/016592-0","article-title":"Germination of spores of Clostridium difficile strains, including isolates from a hospital outbreak of Clostridium difficile-associated disease (CDAD)","volume":"154","author":"Paredes-Sabja","year":"2008","journal-title":"Microbiology"},{"key":"10.1016\/j.ijpharm.2016.12.005_bib0135","first-page":"e56","article-title":"Probiotics for the prevention of antibiotic-associated diarrhea and Clostridium difficile infection among hospitalized patients: systematic review and meta-analysis","volume":"7","author":"Pattani","year":"2013","journal-title":"Open Med."},{"key":"10.1016\/j.ijpharm.2016.12.005_bib0140","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1128\/AAC.46.6.1647-1650.2002","article-title":"Reassessment of Clostridium difficile susceptibility to metronidazole and vancomycin","volume":"46","author":"Pelaez","year":"2002","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ijpharm.2016.12.005_bib0145","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1086\/430315","article-title":"Increasing risk of relapse after treatment of Clostridium difficile colitis in Quebec, Canada","volume":"40","author":"Pepin","year":"2005","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.ijpharm.2016.12.005_bib0150","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD004611.pub2","article-title":"Probiotics for treatment of Clostridium difficile-associated colitis in adults","author":"Pillai","year":"2008","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.ijpharm.2016.12.005_bib0155","doi-asserted-by":"crossref","first-page":"S11","DOI":"10.1016\/S0002-9270(99)00809-6","article-title":"The effect of probiotics on Clostridium difficile diarrhea","volume":"95","author":"Pochapin","year":"2000","journal-title":"Am. J. Gastroenterol."},{"key":"10.1016\/j.ijpharm.2016.12.005_bib0160","first-page":"957","article-title":"Probiotics for the prevention of Clostridium difficile","volume":"59","author":"Rainkie","year":"2013","journal-title":"Can. Fam. Phys."},{"key":"10.1016\/j.ijpharm.2016.12.005_bib0165","doi-asserted-by":"crossref","first-page":"4215","DOI":"10.1128\/JB.00488-10","article-title":"Kinetic evidence for the presence of putative germination receptors in Clostridium difficile spores","volume":"192","author":"Ramirez","year":"2010","journal-title":"J. Bacteriol."},{"key":"10.1016\/j.ijpharm.2016.12.005_bib0170","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1038\/nrmicro2164","article-title":"Clostridium difficile infection: new developments in epidemiology and pathogenesis","volume":"7","author":"Rupnik","year":"2009","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.ijpharm.2016.12.005_bib0175","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.ijpharm.2013.12.037","article-title":"An in vitro test of the efficacy of silver-containing wound dressings against Staphylococcus aureus and Pseudomonas aeruginosa in simulated wound fluid","volume":"462","author":"Said","year":"2014","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2016.12.005_bib0180","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.anaerobe.2013.02.006","article-title":"In vitro inhibition of Clostridium difficile and Clostridium perfringens by commercial probiotic strains","volume":"20","author":"Schoster","year":"2013","journal-title":"Anaerobe"},{"key":"10.1016\/j.ijpharm.2016.12.005_bib0185","first-page":"566","article-title":"Therapy: probiotics do not reduce antibiotic-associated or Clostridium difficile diarrhoea in older hospitalized patients","volume":"10","author":"Smith","year":"2013","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.ijpharm.2016.12.005_bib0190","doi-asserted-by":"crossref","first-page":"2505","DOI":"10.1128\/JB.01765-07","article-title":"Bile salts and glycine as cogerminants for Clostridium difficile spores","volume":"190","author":"Sorg","year":"2008","journal-title":"J. Bacteriol."},{"key":"10.1016\/j.ijpharm.2016.12.005_bib0195","doi-asserted-by":"crossref","first-page":"187","DOI":"10.3949\/ccjm.73.2.187","article-title":"Clostridium difficile-associated disease: new challenges from an established pathogen","volume":"73","author":"Sunenshine","year":"2006","journal-title":"Cleve. Clin. J. Med."},{"key":"10.1016\/j.ijpharm.2016.12.005_bib0200","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1016\/j.anaerobe.2012.08.004","article-title":"In vitro evaluation of the antimicrobial activity of a range of probiotics against pathogens: evidence for the effects of organic acids","volume":"18","author":"Tejero-Sarinena","year":"2012","journal-title":"Anaerobe"},{"key":"10.1016\/j.ijpharm.2016.12.005_bib0205","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.anaerobe.2006.03.004","article-title":"Inhibition of Clostridium difficile growth and adhesion to enterocytes by Bifidobacterium supernatants","volume":"12","author":"Trejo","year":"2006","journal-title":"Anaerobe"},{"key":"10.1016\/j.ijpharm.2016.12.005_bib0210","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/0016-5085(81)90644-2","article-title":"Isolation rates and toxigenic potential of Clostridium difficile isolates from various patient populations","volume":"81","author":"Viscidi","year":"1981","journal-title":"Gastroenterology"},{"key":"10.1016\/j.ijpharm.2016.12.005_bib0215","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.jhin.2008.05.004","article-title":"Costs of nosocomial Clostridium difficile-associated diarrhoea","volume":"70","author":"Vonberg","year":"2008","journal-title":"J. Hosp. Infect."},{"key":"10.1016\/j.ijpharm.2016.12.005_bib0220","doi-asserted-by":"crossref","first-page":"2223","DOI":"10.1111\/j.1365-2672.2008.03965.x","article-title":"Physical and chemical factors influencing the germination of Clostridium difficile spores","volume":"105","author":"Wheeldon","year":"2008","journal-title":"J. Appl. Microbiol."},{"key":"10.1016\/j.ijpharm.2016.12.005_bib0225","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1128\/JCM.18.4.1017-1019.1983","article-title":"Efficiency of various bile salt preparations for stimulation of Clostridium difficile spore germination","volume":"18","author":"Wilson","year":"1983","journal-title":"J. Clin. Microbiol."}],"container-title":["International Journal of Pharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S037851731631136X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S037851731631136X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,9,27]],"date-time":"2020-09-27T18:45:57Z","timestamp":1601232357000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S037851731631136X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,1]]},"references-count":45,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2017,1]]}},"alternative-id":["S037851731631136X"],"URL":"https:\/\/doi.org\/10.1016\/j.ijpharm.2016.12.005","relation":{},"ISSN":["0378-5173"],"issn-type":[{"value":"0378-5173","type":"print"}],"subject":[],"published":{"date-parts":[[2017,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"In vitro inhibition of Clostridium difficile by commercial probiotics: A microcalorimetric study","name":"articletitle","label":"Article Title"},{"value":"International Journal of Pharmaceutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijpharm.2016.12.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}